KAKEN PHARMACEUTIAL CO., LTD. (4521)

Market cap
¥191.8B
P/E ratio
68.7x
A Japanese pharmaceutical company that manufactures and sells medicines, medical devices, and agricultural chemicals while also operating real estate leasing.
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 202521,279+113.84%
Mar 31, 20249,951+14.03%
Mar 31, 20238,727-50.25%
Mar 31, 202217,542-3.73%
Mar 31, 202118,222-32.38%
Mar 31, 202026,946+7.90%
Mar 31, 201924,972-10.35%
Mar 31, 201827,854-10.09%
Mar 31, 201730,981-12.40%
Mar 31, 201635,365+73.41%
Mar 31, 201520,394+31.40%
Mar 31, 201415,521+8.92%
Mar 31, 201314,250-3.74%
Mar 31, 201214,803
AI Chat